Clinica e Investigacion en Arteriosclerosis
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.9 | Q3 | 36.0% | 0.444 | Q3 | 56.8% |
| 2024 | 1.9 | Q3 | 37.4% | 0.502 | Q3 | 62.3% |
| 2023 | 1.9 | Q3 | 40.0% | 0.424 | Q3 | 59.6% |
| 2022 | 1.6 | 30.6% | 0.360 | Q3 | 56.1% | |
| 2021 | — | 30.4% | 0.325 | Q3 | 53.9% | |
| 2020 | — | — | 0.298 | Q3 | 50.2% | |
| 2019 | — | — | 0.277 | Q3 | 49.8% | |
| 2018 | — | — | 0.241 | Q3 | 42.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1578-1879
ISSN
0214-9168
country
EScoverage
2007-2026